Suchbegriffe: HEART FAILURE WITH PRESERVED EJECTION FRACTION, . Treffer: 52
Dachs, TM; Duca, F; Rettl, R; Binder-Rodriguez, C; Dalos, D; Ligios, LC; Kammerlander, A; Grunig, E; Pretsch, I; Steringer-Mascherbauer, R; Ablasser, K; Wargenau, M; Mascherbauer, J; Lang, IM; Hengstenberg, C; Badr-Eslam, R; Kastner, J; Bonderman, D
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial
EUR HEART J. 2022;
Doi: 10.1093/eurheartj/ehac389
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Eaton, DM; Berretta, RM; Lynch, JE; Travers, JG; Pfeiffer, RD; Hulke, ML; Zhao, H; Hobby, ARH; Schena, G; Johnson, JP; Wallner, M; Lau, E; Lam, MPY; Woulfe, KC; Tucker, NR; McKinsey, TA; Wolfson, MR; Houser, SR
Sex-specific responses to slow progressive pressure overload in a large animal model of HFpEF.
Am J Physiol Heart Circ Physiol. 2022; 323(4):H797-H817
Doi: 10.1152/ajpheart.00374.2022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Eaton, DM; Martin, TG; Kasa, M; Djalinac, N; Ljubojevic-Holzer, S; Von, Lewinski, D; Pöttler, M; Kampaengsri, T; Krumphuber, A; Scharer, K; Maechler, H; Zirlik, A; McKinsey, TA; Kirk, JA; Houser, SR; Rainer, PP; Wallner, M
HDAC Inhibition Regulates Cardiac Function by Increasing Myofilament Calcium Sensitivity and Decreasing Diastolic Tension.
Pharmaceutics. 2022; 14(7):
Doi: 10.3390/pharmaceutics14071509
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Granegger, M; Gross, C; Siemer, D; Escher, A; Sandner, S; Schweiger, M; Laufer, G; Zimpfer, D
Comparison of device-based therapy options for heart failure with preserved ejection fraction: a simulation study.
Sci Rep. 2022; 12(1): 5761
Doi: 10.1038/s41598-022-09637-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Koser, F; Hobbach, AJ; Abdellatif, M; Herbst, V; Türk, C; Reinecke, H; Krüger, M; Sedej, S; Linke, WA
Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment.
Life Sci. 2022; 309:120998
Doi: 10.1016/j.lfs.2022.120998
Web of Science
PubMed
FullText
FullText_MUG
Abdellatif, M; Sedej, S; Kroemer, G
NAD+ Metabolism in Cardiac Health, Aging, and Disease.
Circulation. 2021; 144(22): 1795-1817.
Doi: 10.1161/CIRCULATIONAHA.121.056589
Web of Science
PubMed
FullText
FullText_MUG
Abdellatif, M; Trummer-Herbst, V; Koser, F; Durand, S; Adão, R; Vasques-Nóvoa, F; Freundt, JK; Voglhuber, J; Pricolo, MR; Kasa, M; Türk, C; Aprahamian, F; Herrero-Galán, E; Hofer, SJ; Pendl, T; Rech, L; Kargl, J; Anto-Michel, N; Ljubojevic-Holzer, S; Schipke, J; Brandenberger, C; Auer, M; Schreiber, R; Koyani, CN; Heinemann, A; Zirlik, A; Schmidt, A; von Lewinski, D; Scherr, D; Rainer, PP; von Maltzahn, J; Mühlfeld, C; Krüger, M; Frank, S; Madeo, F; Eisenberg, T; Prokesch, A; Leite-Moreira, AF; Lourenço, AP; Alegre-Cebollada, J; Kiechl, S; Linke, WA; Kroemer, G; Sedej, S
Nicotinamide for the treatment of heart failure with preserved ejection fraction.
Sci Transl Med. 2021; 13(580): eabd7064
Doi: 10.1126/scitranslmed.abd7064
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gibb, AA; Murray, EK; Eaton, DM; Huynh, AT; Tomar, D; Garbincius, JF; Kolmetzky, DW; Berretta, RM; Wallner, M; Houser, SR; Elrod, JW
Molecular Signature of HFpEF: Systems Biology in a Cardiac-Centric Large Animal Model.
JACC Basic Transl Sci. 2021; 6(8):650-672
Doi: 10.1016/j.jacbts.2021.07.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mühlfeld, C; Rajces, A; Manninger, M; Alogna, A; Wierich, MC; Scherr, D; Post, H; Schipke, J
A transmural gradient of myocardial remodeling in early-stage heart failure with preserved ejection fraction in the pig.
J Anat. 2020; 236(3):531-539
Doi: 10.1111/joa.13117
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wallner, M; Eaton, DM; Berretta, RM; Liesinger, L; Schittmayer, M; Gindlhuber, J; Wu, J; Jeong, MY; Lin, YH; Borghetti, G; Baker, ST; Zhao, H; Pfleger, J; Blass, S; Rainer, PP; von Lewinski, D; Bugger, H; Mohsin, S; Graier, WF; Zirlik, A; McKinsey, TA; Birner-Gruenberger, R; Wolfson, MR; Houser, SR
HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction.
Sci Transl Med. 2020; 12(525):
Doi: 10.1126/scitranslmed.aay7205
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Belyavskiy, E; Morris, DA; Url-Michitsch, M; Verheyen, N; Meinitzer, A; Radhakrishnan, AK; Kropf, M; Frydas, A; Ovchinnikov, AG; Schmidt, A; Tadic, M; Genger, M; Lindhorst, R; Bobenko, A; Tschöpe, C; Edelmann, F; Pieske-Kraigher, E; Pieske, B
Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study.
ESC Heart Fail. 2019; 6(1):146-153
Doi: 10.1002/ehf2.12375
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gergei, I; Krämer, BK; Scharnagl, H; Stojakovic, T; März, W
Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction.
Peptides. 2019; 111:112-117
Doi: 10.1016/j.peptides.2018.04.003
Web of Science
PubMed
FullText
FullText_MUG
Gollmer, J; Zirlik, A; Bugger, H
Established and Emerging Mechanisms of Diabetic Cardiomyopathy.
J Lipid Atheroscler. 2019; 8(1):26-47
Doi: 10.12997/jla.2019.8.1.26
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Nolte, K; Herrmann-Lingen, C; Platschek, L; Holzendorf, V; Pilz, S; Tomaschitz, A; Düngen, HD; Angermann, CE; Hasenfuß, G; Pieske, B; Wachter, R; Edelmann, F
Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
ESC Heart Fail. 2019; 6(2): 262-270.
Doi: 10.1002/ehf2.12413
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Primessnig, U; Bracic, T; Levijoki, J; Otsomaa, L; Pollesello, P; Falcke, M; Pieske, B; Heinzel, FR
Long-term effects of Na+ /Ca2+ exchanger inhibition with ORM-11035 improves cardiac function and remodelling without lowering blood pressure in a model of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2019; 21(12):1543-1552
Doi: 10.1002/ejhf.1619
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Alogna, A; Schwarzl, M; Manninger, M; Hamdani, N; Zirngast, B; Kloth, B; Steendijk, P; Verderber, J; Zweiker, D; Westermann, D; Blankenberg, S; Maechler, H; Tschöpe, C; Linke, WA; Marsche, G; Pieske, BM; Post, H
Acute stimulation of the soluble guanylate cyclase does not impact on left ventricular capacitance in normal and hypertrophied porcine hearts in vivo.
Am J Physiol Heart Circ Physiol. 2018; 315(3):H669-H680
Doi: 10.1152/ajpheart.00510.2017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lourenço, AP; Leite-Moreira, AF; Balligand, JL; Bauersachs, J; Dawson, D; de Boer, RA; de Windt, LJ; Falcão-Pires, I; Fontes-Carvalho, R; Franz, S; Giacca, M; Hilfiker-Kleiner, D; Hirsch, E; Maack, C; Mayr, M; Pieske, B; Thum, T; Tocchetti, CG; Brutsaert, DL; Heymans, S
An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.
Eur J Heart Fail. 2018; 20(2):216-227
Doi: 10.1002/ejhf.1059
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Solomon, SD; Rizkala, AR; Lefkowitz, MP; Shi, VC; Gong, J; Anavekar, N; Anker, SD; Arango, JL; Arenas, JL; Atar, D; Ben-Gal, T; Boytsov, SA; Chen, CH; Chopra, VK; Cleland, J; Comin-Colet, J; Duengen, HD; Echeverría Correa, LE; Filippatos, G; Flammer, AJ; Galinier, M; Godoy, A; Goncalvesova, E; Janssens, S; Katova, T; Køber, L; Lelonek, M; Linssen, G; Lund, LH; O'Meara, E; Merkely, B; Milicic, D; Oh, BH; Perrone, SV; Ranjith, N; Saito, Y; Saraiva, JF; Shah, S; Seferovic, PM; Senni, M; Sibulo, AS; Sim, D; Sweitzer, NK; Taurio, J; Vinereanu, D; Vrtovec, B; Widimský, J; Yilmaz, MB; Zhou, J; Zweiker, R; Anand, IS; Ge, J; Lam, CSP; Maggioni, AP; Martinez, F; Packer, M; Pfeffer, MA; Pieske, B; Redfield, MM; Rouleau, JL; Van Veldhuisen, DJ; Zannad, F; Zile, MR; McMurray, JJV
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
Circ Heart Fail. 2018; 11(7):e004962-e004962
Doi: 10.1161/CIRCHEARTFAILURE.118.004962
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schipke, J; Brandenberger, C; Rajces, A; Manninger, M; Alogna, A; Post, H; Mühlfeld, C
Assessment of cardiac fibrosis: a morphometric method comparison for collagen quantification.
J Appl Physiol (1985). 2017; 122(4):1019-1030
Doi: 10.1152/japplphysiol.00987.2016
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wallner, M; Eaton, DM; Berretta, RM; Borghetti, G; Wu, J; Baker, ST; Feldsott, EA; Sharp, TE; Mohsin, S; Oyama, MA; von Lewinski, D; Post, H; Wolfson, MR; Houser, SR
A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function.
Sci Rep. 2017; 7(1):16587-16587
Doi: 10.1038/s41598-017-15851-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Winter, MP; Kleber, ME; Koller, L; Sulzgruber, P; Scharnagl, H; Delgado, G; Goliasch, G; März, W; Niessner, A
Prognostic significance of tPA/PAI-1 complex in patients with heart failure and preserved ejection fraction.
Thromb Haemost. 2017; 117(3):471-478
Doi: 10.1160/TH16-08-0600
Web of Science
PubMed
FullText
FullText_MUG
Abdellatif, M; Leite, S; Alaa, M; Oliveira-Pinto, J; Tavares-Silva, M; Fontoura, D; Falcão-Pires, I; Leite-Moreira, AF; Lourenço, AP
Spectral transfer function analysis of respiratory hemodynamic fluctuations predicts end-diastolic stiffness in preserved ejection fraction heart failure.
Am J Physiol Heart Circ Physiol. 2016; 310(1):H4-13
Doi: 10.1152/ajpheart.00399.2015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hölscher, ME; Bode, C; Bugger, H
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Int J Mol Sci. 2016; 17(12):
Doi: 10.3390/ijms17122136
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Primessnig, U; Schönleitner, P; Höll, A; Pfeiffer, S; Bracic, T; Rau, T; Kapl, M; Stojakovic, T; Glasnov, T; Leineweber, K; Wakula, P; Antoons, G; Pieske, B; Heinzel, FR
Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2016; 18(8):987-997
Doi: 10.1002/ejhf.524
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Reiter, U; Reiter, G; Manninger, M; Adelsmayr, G; Schipke, J; Alogna, A; Rajces, A; Stalder, AF; Greiser, A; Mühlfeld, C; Scherr, D; Post, H; Pieske, B; Fuchsjäger, M
Early-stage heart failure with preserved ejection fraction in the pig: a cardiovascular magnetic resonance study.
J Cardiovasc Magn Reson. 2016; 18(1):63
Doi: 10.1186/s12968-016-0283-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zile, MR; Jhund, PS; Baicu, CF; Claggett, BL; Pieske, B; Voors, AA; Prescott, MF; Shi, V; Lefkowitz, M; McMurray, JJ; Solomon, SD; Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction (PARAMOUNT) Investigators
Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
Circ Heart Fail. 2016; 9(1):
Doi: 10.1161/CIRCHEARTFAILURE.115.002551
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Edelmann, F; Holzendorf, V; Wachter, R; Nolte, K; Schmidt, AG; Kraigher-Krainer, E; Duvinage, A; Unkelbach, I; Düngen, HD; Tschöpe, C; Herrmann-Lingen, C; Halle, M; Hasenfuss, G; Gelbrich, G; Stough, WG; Pieske, BM
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.
Eur J Heart Fail. 2015; 17(2):214-223
Doi: 10.1002/ejhf.203
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ferrari, R; Böhm, M; Cleland, JG; Paulus, WJ; Pieske, B; Rapezzi, C; Tavazzi, L
Heart failure with preserved ejection fraction: uncertainties and dilemmas.
Eur J Heart Fail. 2015; 17(7):665-671
Doi: 10.1002/ejhf.304
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Heinzel, FR; Hohendanner, F; Jin, G; Sedej, S; Edelmann, F
Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.
J Appl Physiol (1985). 2015; 119(10):1233-1242
Doi: 10.1152/japplphysiol.00374.2015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kleber, ME; Koller, L; Goliasch, G; Sulzgruber, P; Scharnagl, H; Silbernagel, G; Grammer, TB; Delgado, G; Tomaschitz, A; Pilz, S; März, W; Niessner, A
Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
Circ Heart Fail. 2015; 8(1):25-32
Doi: 10.1161/CIRCHEARTFAILURE.114.001478
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Leite, S; Oliveira-Pinto, J; Tavares-Silva, M; Abdellatif, M; Fontoura, D; Falcão-Pires, I; Leite-Moreira, AF; Lourenço, AP
Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study.
Am J Physiol Heart Circ Physiol. 2015; 308(12): H1556-H1563.
Doi: 10.1152/ajpheart.00076.2015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Leite, S; Rodrigues, S; Tavares-Silva, M; Oliveira-Pinto, J; Alaa, M; Abdellatif, M; Fontoura, D; Falcão-Pires, I; Gillebert, TC; Leite-Moreira, AF; Lourenço, AP
Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction.
Am J Physiol Heart Circ Physiol. 2015; 309(10):H1648-H1654
Doi: 10.1152/ajpheart.00397.2015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Nolte, K; Herrmann-Lingen, C; Wachter, R; Gelbrich, G; Düngen, HD; Duvinage, A; Hoischen, N; von Oehsen, K; Schwarz, S; Hasenfuss, G; Halle, M; Pieske, B; Edelmann, F
Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial.
Eur J Prev Cardiol. 2015; 22(5):582-593
Doi: 10.1177/2047487314526071
Web of Science
PubMed
FullText
FullText_MUG
Schwarzl, M; Hamdani, N; Seiler, S; Alogna, A; Manninger, M; Reilly, S; Zirngast, B; Kirsch, A; Steendijk, P; Verderber, J; Zweiker, D; Eller, P; Höfler, G; Schauer, S; Eller, K; Maechler, H; Pieske, BM; Linke, WA; Casadei, B; Post, H
A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
Am J Physiol Heart Circ Physiol. 2015; 309(9):H1407-18
Doi: 10.1152/ajpheart.00542.2015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dorfs, S; Zeh, W; Hochholzer, W; Jander, N; Kienzle, RP; Pieske, B; Neumann, FJ
Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction.
Eur Heart J. 2014; 35(44):3103-3112
Doi: 10.1093/eurheartj/ehu315
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gori, M; Lam, CS; Gupta, DK; Santos, AB; Cheng, S; Shah, AM; Claggett, B; Zile, MR; Kraigher-Krainer, E; Pieske, B; Voors, AA; Packer, M; Bransford, T; Lefkowitz, M; McMurray, JJ; Solomon, SD; PARAMOUNT Investigators
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2014; 16(5):535-542
Doi: 10.1002/ejhf.67
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gori, M; Senni, M; Gupta, DK; Charytan, DM; Kraigher-Krainer, E; Pieske, B; Claggett, B; Shah, AM; Santos, AB; Zile, MR; Voors, AA; McMurray, JJ; Packer, M; Bransford, T; Lefkowitz, M; Solomon, SD; PARAMOUNT Investigators
Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction.
Eur Heart J. 2014; 35(48):3442-3451
Doi: 10.1093/eurheartj/ehu254
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jhund, PS; Claggett, B; Packer, M; Zile, MR; Voors, AA; Pieske, B; Lefkowitz, M; Shi, V; Bransford, T; McMurray, JJ; Solomon, SD
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
Eur J Heart Fail. 2014; 16(6):671-677
Doi: 10.1002/ejhf.76
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jhund, PS; Claggett, BL; Voors, AA; Zile, MR; Packer, M; Pieske, BM; Kraigher-Krainer, E; Shah, AM; Prescott, MF; Shi, V; Lefkowitz, M; McMurray, JJ; Solomon, SD; PARAMOUNT Investigators
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.
Circ Heart Fail. 2014; 7(6):953-959
Doi: 10.1161/CIRCHEARTFAILURE.114.001427
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Koller, L; Kleber, M; Goliasch, G; Sulzgruber, P; Scharnagl, H; Silbernagel, G; Grammer, T; Delgado, G; Tomaschitz, A; Pilz, S; März, W; Niessner, A
C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.
Eur J Heart Fail. 2014; 16(7):758-766
Doi: 10.1002/ejhf.104
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kraigher-Krainer, E; Shah, AM; Gupta, DK; Santos, A; Claggett, B; Pieske, B; Zile, MR; Voors, AA; Lefkowitz, MP; Packer, M; McMurray, JJ; Solomon, SD; PARAMOUNT Investigators
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
J Am Coll Cardiol. 2014; 63(5):447-456
Doi: 10.1016/j.jacc.2013.09.052
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Santos, AB; Kraigher-Krainer, E; Bello, N; Claggett, B; Zile, MR; Pieske, B; Voors, AA; McMurray, JJ; Packer, M; Bransford, T; Lefkowitz, M; Shah, AM; Solomon, SD
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction.
Eur Heart J. 2014; 35(1):42-47
Doi: 10.1093/eurheartj/eht427
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Santos, AB; Kraigher-Krainer, E; Gupta, DK; Claggett, B; Zile, MR; Pieske, B; Voors, AA; Lefkowitz, M; Bransford, T; Shi, V; Packer, M; McMurray, JJ; Shah, AM; Solomon, SD; PARAMOUNT Investigators
Impaired left atrial function in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2014; 16(10):1096-1103
Doi: 10.1002/ejhf.147
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Senni, M; Paulus, WJ; Gavazzi, A; Fraser, AG; Díez, J; Solomon, SD; Smiseth, OA; Guazzi, M; Lam, CS; Maggioni, AP; Tschöpe, C; Metra, M; Hummel, SL; Edelmann, F; Ambrosio, G; Stewart Coats, AJ; Filippatos, GS; Gheorghiade, M; Anker, SD; Levy, D; Pfeffer, MA; Stough, WG; Pieske, BM
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.
Eur Heart J. 2014; 35(40):2797-2815
Doi: 10.1093/eurheartj/ehu204
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Suchy, C; Massen, L; Rognmo, O; Van Craenenbroeck, EM; Beckers, P; Kraigher-Krainer, E; Linke, A; Adams, V; Wisløff, U; Pieske, B; Halle, M
Optimising exercise training in prevention and treatment of diastolic heart failure (OptimEx-CLIN): rationale and design of a prospective, randomised, controlled trial.
Eur J Prev Cardiol. 2014; 21(2 Suppl):18-25
Doi: 10.1177/2047487314552764
Web of Science
PubMed
FullText
FullText_MUG
Edelmann, F; Gelbrich, G; Duvinage, A; Stahrenberg, R; Behrens, A; Prettin, C; Kraigher-Krainer, E; Schmidt, AG; Düngen, HD; Kamke, W; Tschöpe, C; Herrmann-Lingen, C; Halle, M; Hasenfuss, G; Wachter, R; Pieske, B
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial.
Int J Cardiol. 2013; 169(6):408-417
Doi: 10.1016/j.ijcard.2013.10.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Weber, T; Wassertheurer, S; O'Rourke, MF; Haiden, A; Zweiker, R; Rammer, M; Hametner, B; Eber, B
Pulsatile hemodynamics in patients with exertional dyspnea - potentially of value in the diagnostic evaluation of suspected heart failure with preserved ejection fraction.
J Am Coll Cardiol. 2013; 61(18): 1874-1883.
Doi: 10.1016/j.jacc.2013.02.013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Conraads, VM; Metra, M; Kamp, O; De Keulenaer, GW; Pieske, B; Zamorano, J; Vardas, PE; Böhm, M; Dei Cas, L
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
EUR J HEART FAIL. 2012; 14(2): 219-225.
Doi: 10.1093/eurjhf/hfr161
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Edelmann, F; Gelbrich, G; Düngen, HD; Fröhling, S; Wachter, R; Stahrenberg, R; Binder, L; Töpper, A; Lashki, DJ; Schwarz, S; Herrmann-Lingen, C; Löffler, M; Hasenfuss, G; Halle, M; Pieske, B
Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study.
J Am Coll Cardiol. 2011; 58(17):1780-1791
Doi: 10.1016/j.jacc.2011.06.054
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Edelmann, F; Stahrenberg, R; Gelbrich, G; Durstewitz, K; Angermann, CE; Düngen, HD; Scheffold, T; Zugck, C; Maisch, B; Regitz-Zagrosek, V; Hasenfuss, G; Pieske, BM; Wachter, R
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction.
Clin Res Cardiol. 2011; 100(9):755-764
Doi: 10.1007/s00392-011-0305-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Weitere 50 Treffer anzeigen